By Ed Devlin2024-01-25T14:08:00
Biotech firm Infinite Roots has closed a $58m (£45.5m) series B funding round as the business looks commercialise its technology and kickstart product launches worldwide
Already have an account? Sign in here
Already have an account? Sign in here
Due to a critical PHP security update affecting our production systems, this week's magazine will be delayed. We apologise for any inconvenience and appreciate your patience while the issue is resolved